Department of Clinical Laboratory, The Children's Hospital Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
Department of Pathology, The Children's Hospital Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
J Clin Lab Anal. 2022 Oct;36(10):e24661. doi: 10.1002/jcla.24661. Epub 2022 Aug 21.
Detection of classic Hodgkin lymphoma (cHL) neoplastic cells using flow cytometric immunophenotyping (FCI) remains limited. We hypothesized that characterization of the reactive infiltrates could assist in diagnosing cHL in children.
FCI using four-color staining approaches was performed on 156 lymph node specimens with the following histopathologic diagnoses: cHL (25 cases), reactive lymphoid hyperplasia (RLH, 44 cases), and non-Hodgkin lymphoma (87 cases).
The overall concordance of FCI data with the histopathologic results of these cases was 81.4%. A reactive expansion of T-cells with increased expression of CD45RO was present in the reactive infiltrate of cHL (CD45RO/CD3, 67.5%) and Epstein-Barr virus (EBV) infected RLH (62.7%) but not in EBV-negative RLH (28.0%). The mean fluorescence intensity (MFI) of CD7 was higher for cHL and differed significantly from EBV-positive RLH (138.5 vs. 63.8). A proposed diagnostic algorithm markedly elevated the overall concordance rate from 81.4% to 97.4%.
Immunophenotyping the reactive infiltrate of lymphoid tissue using flow cytometry is a reliable supplement to histopathology for the rapid diagnosis of pediatric cHL.
使用流式细胞仪免疫表型分析(FCI)检测经典霍奇金淋巴瘤(cHL)肿瘤细胞仍然有限。我们假设,对反应性浸润物的特征描述可以帮助诊断儿童 cHL。
对 156 个淋巴结标本进行了四色染色方法的 FCI,这些标本的组织病理学诊断如下:cHL(25 例)、反应性淋巴组织增生(RLH,44 例)和非霍奇金淋巴瘤(87 例)。
FCI 数据与这些病例的组织病理学结果总体一致性为 81.4%。在 cHL(CD45RO/CD3,67.5%)和 EBV 感染的 RLH(62.7%)的反应性浸润物中存在 T 细胞的反应性扩增,其 CD45RO 表达增加,但在 EBV 阴性的 RLH 中不存在(28.0%)。CD7 的平均荧光强度(MFI)在 cHL 中更高,与 EBV 阳性的 RLH 有显著差异(138.5 比 63.8)。提出的诊断算法将总体一致性率从 81.4%显著提高到 97.4%。
使用流式细胞术对淋巴组织的反应性浸润物进行免疫表型分析是组织病理学快速诊断儿科 cHL 的可靠补充。